Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agenus Inc
(NQ:
AGEN
)
5.800
+0.330 (+6.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Agenus Inc
< Previous
1
2
3
4
5
Next >
50 Biggest Movers From Yesterday
June 18, 2021
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Agenus Stock Is Marching Higher Today
June 17, 2021
The biotech took a major step toward becoming a commercial-stage cancer company.
Via
The Motley Fool
Exposures
Product Safety
34 Stocks Moving In Thursday's Mid-Day Session
June 17, 2021
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration statement in connect with the proposed merger...
Via
Benzinga
What's Going On With Agenus Stock Today?
May 18, 2021
Agenus Inc (NASDAQ:AGEN) shares are trading higher by 35.2...
Via
Benzinga
Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer
June 17, 2021
The FDA has accepted for review Agenus Inc's (NASDAQ: AGEN) marketing application seeking approval for balstilimab for recurrent or metastatic cervical cancer...
Via
Benzinga
Exposures
Product Safety
8 Health Care Stocks Showing Unusual Options Activity In Today's Session
June 11, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...
Via
Benzinga
75 Biggest Movers From Yesterday
June 09, 2021
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Why Agenus Stock Is Jumping Today
June 08, 2021
There was some positive news, but it probably wasn't a huge catalyst for the stock.
Via
The Motley Fool
Exposures
Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60%
May 22, 2021
The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and...
Via
Talk Markets
2 Grossly Undervalued Biotech Stocks That Could Double Your Money
May 19, 2021
Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.
Via
The Motley Fool
Exposures
COVID-19
58 Biggest Movers From Yesterday
May 19, 2021
Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...
Via
Benzinga
Why Agenus Stock Skyrocketed Today
May 18, 2021
The biotech announced a big licensing deal with Bristol Myers Squibb.
Via
The Motley Fool
Mid-Afternoon Market Update: Nasdaq Turns Negative; Ultralife Shares Spike Higher
May 18, 2021
Toward the end of trading Tuesday, the Dow traded down 0.39% to 34,192.78 while the NASDAQ fell 0.11% to 13,364.14. The S&P also fell, dropping 0.42% to 4,145.60. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 18, 2021
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Mid-Day Market Update: TOMI Environmental Solutions Falls After Q1 Results; Agenus Shares Jump
May 18, 2021
Midway through trading Tuesday, the Dow traded down 0.16% to 34,272.59 while the NASDAQ rose 0.69% to 13,470.97. The S&P also rose, gaining 0.03% to 4,164.63. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
42 Stocks Moving In Tuesday's Mid-Day Session
May 18, 2021
Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Walmart Tops Q1 Expectations
May 18, 2021
Following the market opening Tuesday, the Dow traded down 0.23% to 34,248.63 while the NASDAQ rose 0.39% to 13,431.72. The S&P also fell, dropping 0.13% to 4,158.02. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors
May 18, 2021
Bristol-Myers Squibb Co (NYSE: BMY) and Agenus Inc (NASDAQ: AGEN) have entered into a global exclusive license agreement, under which Bristol Myers will...
Via
Benzinga
Why Agenus Stock Tumbled Today
May 06, 2021
The company announced mixed Q1 results on a day when many biotech stocks were sinking.
Via
The Motley Fool
Agenus Inc (AGEN) Q1 2021 Earnings Call Transcript
May 06, 2021
AGEN earnings call for the period ending April 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.